Landore Resources (LND) Competitors GBX 2.43 -0.07 (-2.68%) As of 12:28 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesInsider TradesBuy This Stock LND vs. AVO, FDP, TED, ZNWD, GSP, 1SN, TUN, MET1, POW, and ARCMShould you be buying Landore Resources stock or one of its competitors? The main competitors of Landore Resources include Advanced Oncotherapy (AVO), FD Technologies (FDP), Ted Baker (TED), Zinnwald Lithium (ZNWD), Gensource Potash (GSP), First Tin (1SN), Tungsten West (TUN), Metals One (MET1), Power Metal Resources (POW), and Arc Minerals (ARCM). Landore Resources vs. Its Competitors Advanced Oncotherapy FD Technologies Ted Baker Zinnwald Lithium Gensource Potash First Tin Tungsten West Metals One Power Metal Resources Arc Minerals Landore Resources (LON:LND) and Advanced Oncotherapy (LON:AVO) are both small-cap agriculture companies, but which is the superior investment? We will compare the two companies based on the strength of their analyst recommendations, dividends, valuation, earnings, profitability, risk, institutional ownership and media sentiment. Which has more volatility & risk, LND or AVO? Landore Resources has a beta of -0.15, indicating that its share price is 115% less volatile than the S&P 500. Comparatively, Advanced Oncotherapy has a beta of 0.06, indicating that its share price is 94% less volatile than the S&P 500. Which has better valuation & earnings, LND or AVO? Landore Resources is trading at a lower price-to-earnings ratio than Advanced Oncotherapy, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioLandore ResourcesN/AN/A-£3.77M-£1.16-2.10Advanced OncotherapyN/AN/A-£32.60M-£0.07N/A Is LND or AVO more profitable? Advanced Oncotherapy's return on equity of -67.34% beat Landore Resources' return on equity.Company Net Margins Return on Equity Return on Assets Landore ResourcesN/A -217.63% -106.31% Advanced Oncotherapy N/A -67.34%-11.73% Do insiders and institutionals believe in LND or AVO? 3.2% of Landore Resources shares are owned by institutional investors. Comparatively, 17.8% of Advanced Oncotherapy shares are owned by institutional investors. 39.6% of Landore Resources shares are owned by company insiders. Comparatively, 47.5% of Advanced Oncotherapy shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Does the media prefer LND or AVO? In the previous week, Landore Resources' average media sentiment score of 0.00 equaled Advanced Oncotherapy'saverage media sentiment score. Company Overall Sentiment Landore Resources Neutral Advanced Oncotherapy Neutral SummaryAdvanced Oncotherapy beats Landore Resources on 6 of the 8 factors compared between the two stocks. Get Landore Resources News Delivered to You Automatically Sign up to receive the latest news and ratings for LND and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LND vs. The Competition Export to ExcelMetricLandore ResourcesOther Industrial Metals & Mining IndustryMaterials SectorLON ExchangeMarket Cap£7.75M£1.08B£3.34B£3.09BDividend Yield6.74%6.19%5.18%5.04%P/E Ratio-2.10141.49118.28174.56Price / SalesN/A21,516.3830,067,542,409,940,300.00282,771.09Price / Cash21.0024.7024.0127.94Price / Book2.457.435.875.38Net Income-£3.77M£71.98M£148.86M£5.89B7 Day Performance-6.42%1.45%1.34%-0.04%1 Month Performance-13.78%5.62%3.65%0.72%1 Year Performance-36.90%47.27%33.57%64.34% Landore Resources Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LNDLandore ResourcesN/AGBX 2.43-2.7%N/A-34.2%£7.75MN/A-2.106Gap DownHigh Trading VolumeAVOAdvanced OncotherapyN/AN/AN/AN/A£9.50MN/A-25.003,900Gap DownFDPFD TechnologiesN/AGBX 2,450flatN/A+64.4%£544.43M£196.89M-16.9740,100TEDTed BakerN/AN/AN/AN/A£202.71M£428.24M-5.69740ZNWDZinnwald LithiumN/AGBX 5.20+2.0%N/A-37.4%£29.52MN/A-11,640.9223GSPGensource PotashN/AN/AN/AN/A£23.61MN/A-525.00N/A1SNFirst TinN/AGBX 5.79-1.0%N/A+19.0%£18.44MN/A-579.0027TUNTungsten WestN/AGBX 8.50-0.1%N/A+184.2%£17.70M£804.19K-1.8115MET1Metals OneN/AGBX 5.50+12.2%N/A+562.3%£16.95MN/A-42.183Gap UpHigh Trading VolumePOWPower Metal ResourcesN/AGBX 14.40+2.9%N/A-9.9%£16.65M£83.93K0.0020High Trading VolumeARCMArc MineralsN/AGBX 1+2.6%N/A-43.5%£14.76MN/A1.6035Gap Down Related Companies and Tools Related Companies AVO Competitors FDP Competitors TED Competitors ZNWD Competitors GSP Competitors 1SN Competitors TUN Competitors MET1 Competitors POW Competitors ARCM Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:LND) was last updated on 8/15/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Landore Resources Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Landore Resources With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access